VolitionRx (VNRX) Institutional Ownership $0.68 -0.04 (-5.56%) (As of 11/15/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for VolitionRx (NYSE:VNRX)CurrentInstitutional OwnershipPercentage8.09%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$174.83KNumber ofInstitutional Sellers(last 12 months)0 Get VNRX Insider Trade Alerts Want to know when executives and insiders are buying or selling VolitionRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad WealthPressThe only candlestick pattern worth a darnIt’s widely known that 80% of daily market action is driven by Wall Street algorithms… Now, most people think of the algorithms are “bad” When in reality, they are neither good nor bad… They are simply programmed to buy and sell certain stocks over and over again… But here is the thing… They are predictable… They typically buy the same stocks at the same levels over and over again…Follow this link here and enter your email address to sign up… VolitionRx Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC730,448$439K0.0%+15.1%0.788% 10/29/2024 Ground Swell Capital LLC45,959$28K0.0%+78.8%0.050% 1/17/2024 Silverberg Bernstein Capital Management LLC147,038$105K0.1%N/A0.187% 11/14/2023 Lagoda Investment Management L.P.3,882,850$2.68M1.8%-1.2%4.969% (Data available from 1/1/2016 forward) VNRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VNRX shares? During the previous two years, the following institutional investors and hedge funds held shares of VolitionRx shares: Lagoda Investment Management L.P. ($2.68M), Geode Capital Management LLC ($439K), and Silverberg Bernstein Capital Management LLC ($105K), Ground Swell Capital LLC ($28K).Learn more on VNRX's institutional investors. What percentage of VolitionRx stock is owned by institutional investors? 8.09% of VolitionRx stock is owned by institutional investors. Learn more on VNRX's institutional investor holdings. Which institutional investors have been buying VolitionRx stock? The following institutional investors have purchased VolitionRx stock in the last 24 months: Silverberg Bernstein Capital Management LLC ($147.04K), Geode Capital Management LLC ($95.90K), and Ground Swell Capital LLC ($20.25K). How much institutional buying is happening at VolitionRx? Institutional investors have bought a total of 263,187 shares in the last 24 months. This purchase volume represents approximately $174.83K in transactions. Which VolitionRx major shareholders have been selling company stock? The following institutional investors have sold VolitionRx stock in the last 24 months: Lagoda Investment Management L.P. ($46.26K). How much institutional selling is happening at VolitionRx? Institutional investors have sold a total of 46,260 shares in the last 24 months. This volume of shares sold represents approximately $31.87K in transactions. Related Companies PYXS Major Shareholders GNFT Major Shareholders EDIT Major Shareholders INZY Major Shareholders KOD Major Shareholders CMPX Major Shareholders TSVT Major Shareholders CRBU Major Shareholders OPT Major Shareholders ATAI Major Shareholders This page (NYSE:VNRX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VolitionRx Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share VolitionRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.